KESIMPTA
BNopenfda #6a8a3f53-2062-48ff-9dbe-b939df133ca3lang: en
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Ingredients
- OFATUMUMAB
- Synonyms
- OFATUMUMAB
- Routes
- SUBCUTANEOUS
Extra source metadata
{
"ndc": [
"0078-1007"
],
"rxcui": [
"2390949",
"2390954"
],
"pharm_class_epc": [
"CD20-directed Cytolytic Antibody [EPC]"
],
"pharm_class_moa": [
"CD20-directed Antibody Interactions [MoA]"
]
}Source last updated 2026-05-24T14:38:37.004Z